TP53 and lip and oral cavity carcinoma: Interestingly, heteronemin suppresses p53 expression and activity in cholangiocarcinoma [44] and oral cancer cells [11], suggesting that heteronemin does not induce anti-proliferation via a p53-dependent pathway.